MVRS (Mitral Valve Repair System)

About CardioMech

CardioMech is pioneering a catheter-based solution for mitral regurgitation (MR), a prevalent and serious cardiovascular disease. Its core technology is an artificial chord delivery system (MVRS) implanted via a transfemoral, transseptal route on a beating heart, targeting a simpler procedure than current surgical or transcatheter options. The company is in the clinical stage with an Early Feasibility Study, positioning itself in a large and growing market expected to surpass the TAVR market. As a private, pre-revenue entity, its success hinges on clinical validation, regulatory approval, and navigating a competitive landscape dominated by established players.

Therapeutic Areas